IRTC iRhythm Technologies Inc

  1. Stocks
  2. Healthcare
  3. NASDAQ: IRTC

Price (delayed)

$111.765

Market cap

$3.68B

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$0.42

Enterprise value

$4.16B

?
Relative Growth: Rel. Growth: 89
Relative Strength: Rel. Strength: 24
Relative Valuation: Rel. Valuation: 13
Relative Profitability: Rel. Profitability: 47

iRhythm is a leading digital health care company that creates trusted solutions that detect, predict, and prevent disease. Combining wearable biosensors and cloud-based data analytics with powerful proprietary algorithms, iRhythm ...

Highlights
The EPS has soared by 86% YoY and by 51% from the previous quarter
The company's net income has surged by 85% YoY and by 50% QoQ
The quick ratio has contracted by 28% from the previous quarter and by 27% YoY
Sector: Healthcare
Industry: Medical Devices
Website: http://www.iRhythmTech.com
Peers: MD

Key stats

What are the main financial stats of IRTC

IRTC stock price

How has the iRhythm Technologies stock price performed over time
Intraday
1.12%
1 week
-0.05%
1 month
-13.04%
1 year
-36.3%
YTD
-37.01%
QTD
-6.04%

Financial performance

How have iRhythm Technologies's revenue and profit performed over time
Revenue
$825.34M
Gross profit
$589.74M
Operating income
-$24.87M
Net income
-$13.95M
Gross margin
71.5%
Net margin
-1.7%
The net margin has soared by 88% YoY and by 51% from the previous quarter
The company's net income has surged by 85% YoY and by 50% QoQ
IRTC's operating margin has soared by 81% YoY and by 42% from the previous quarter
The operating income has soared by 76% YoY and by 39% from the previous quarter

Price vs fundamentals

How does IRTC's price correlate with its fundamentals

Growth

What is iRhythm Technologies's growth rate over time

Valuation

What is iRhythm Technologies stock price valuation
P/E
N/A
P/B
19.75
P/S
4.45
EV/EBIT
19,698.68
EV/EBITDA
154.77
EV/Sales
5.04
The EPS has soared by 86% YoY and by 51% from the previous quarter
IRTC's equity has surged by 79% year-on-year and by 15% since the previous quarter
IRTC's P/B is 39% below its last 4 quarters average of 31.9 and 20% below its 5-year quarterly average of 24.4
The P/S is 39% below the 5-year quarterly average of 7.2 and 30% below the last 4 quarters average of 6.3
The revenue has grown by 26% YoY and by 4.8% from the previous quarter

Efficiency

How efficient is iRhythm Technologies business performance
IRTC's return on invested capital has surged by 100% since the previous quarter and by 100% year-on-year
The ROS has soared by 100% from the previous quarter and by 100% YoY
iRhythm Technologies's ROE has soared by 91% YoY and by 56% from the previous quarter
The ROA has soared by 86% YoY and by 50% from the previous quarter

Dividends

What is IRTC's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for IRTC.

Financial health

How did iRhythm Technologies financials performed over time
IRTC's total assets is 20% greater than its total liabilities
The quick ratio has contracted by 28% from the previous quarter and by 27% YoY
The current ratio has declined by 26% since the previous quarter and by 23% year-on-year
IRTC's equity has surged by 79% year-on-year and by 15% since the previous quarter
The debt to equity has contracted by 45% YoY and by 13% from the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.